422 related articles for article (PubMed ID: 23642017)
21. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.
Kurio N; Shimo T; Fukazawa T; Takaoka M; Okui T; Hassan NM; Honami T; Hatakeyama S; Ikeda M; Naomoto Y; Sasaki A
Exp Cell Res; 2011 May; 317(8):1134-46. PubMed ID: 21338601
[TBL] [Abstract][Full Text] [Related]
22. Microsomal prostaglandin E synthase-1 deficiency exacerbates pulmonary fibrosis induced by bleomycin in mice.
Wei B; Cai L; Sun D; Wang Y; Wang C; Chai X; Xie F; Su M; Ding F; Liu J; Yang J; Guan Y; Liu X
Molecules; 2014 Apr; 19(4):4967-85. PubMed ID: 24756129
[TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix proteins: a positive feedback loop in lung fibrosis?
Blaauboer ME; Boeijen FR; Emson CL; Turner SM; Zandieh-Doulabi B; Hanemaaijer R; Smit TH; Stoop R; Everts V
Matrix Biol; 2014 Feb; 34():170-8. PubMed ID: 24291458
[TBL] [Abstract][Full Text] [Related]
24. Gefitinib attenuates murine pulmonary fibrosis induced by bleomycin.
Wang P; Tian Q; Liang ZX; Yang Z; Xu SF; Sun JP; Chen LA
Chin Med J (Engl); 2010 Aug; 123(16):2259-64. PubMed ID: 20819676
[TBL] [Abstract][Full Text] [Related]
25. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
26. Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma.
Kurio N; Shimo T; Fukazawa T; Okui T; Hassan NM; Honami T; Horikiri Y; Hatakeyama S; Takaoka M; Naomoto Y; Sasaki A
Oral Oncol; 2012 Nov; 48(11):1159-70. PubMed ID: 22766511
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis.
Arribillaga L; Dotor J; Basagoiti M; Riezu-Boj JI; Borrás-Cuesta F; Lasarte JJ; Sarobe P; Cornet ME; Feijoó E
Cytokine; 2011 Mar; 53(3):327-33. PubMed ID: 21185199
[TBL] [Abstract][Full Text] [Related]
28. Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis.
Park AM; Kanai K; Itoh T; Sato T; Tsukui T; Inagaki Y; Selman M; Matsushima K; Yoshie O
PLoS One; 2016; 11(2):e0148998. PubMed ID: 26859835
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.
Kono Y; Nishiuma T; Nishimura Y; Kotani Y; Okada T; Nakamura S; Yokoyama M
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):395-404. PubMed ID: 17641298
[TBL] [Abstract][Full Text] [Related]
30. Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts.
Shi-wen X; Parapuram SK; Pala D; Chen Y; Carter DE; Eastwood M; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Jan; 60(1):234-41. PubMed ID: 19116914
[TBL] [Abstract][Full Text] [Related]
31. The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice.
Koyama K; Goto H; Morizumi S; Kagawa K; Nishimura H; Sato S; Kawano H; Toyoda Y; Ogawa H; Homma S; Nishioka Y
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):478-487. PubMed ID: 30540913
[TBL] [Abstract][Full Text] [Related]
32. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
[TBL] [Abstract][Full Text] [Related]
33. Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis.
Semren N; Habel-Ungewitter NC; Fernandez IE; Königshoff M; Eickelberg O; Stöger T; Meiners S
PLoS One; 2015; 10(9):e0136188. PubMed ID: 26340365
[TBL] [Abstract][Full Text] [Related]
34. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
[TBL] [Abstract][Full Text] [Related]
35. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis.
Vyalov SL; Gabbiani G; Kapanci Y
Am J Pathol; 1993 Dec; 143(6):1754-65. PubMed ID: 7504890
[TBL] [Abstract][Full Text] [Related]
36. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
37. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
38. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
39. FAK-dependent regulation of myofibroblast differentiation.
Greenberg RS; Bernstein AM; Benezra M; Gelman IH; Taliana L; Masur SK
FASEB J; 2006 May; 20(7):1006-8. PubMed ID: 16585062
[TBL] [Abstract][Full Text] [Related]
40. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
